GALACTIC-HF multicentre trial showed that omecamtiv mecarbil was superior to placebo at improving cardiovascular outcomes in heart failure patients with low ejection fraction
from Medindia Health News https://ift.tt/2UWyqXm
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
November 25, 2020
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.